NCT05587543View on ClinicalTrials.gov

Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 28, 2022

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2030

Conditions
Nasopharyngeal Carcinoma
Interventions
BEHAVIORAL

PK Blood Collection

All subjects were subjected to PK blood sampling as prescribed by the protocol.

DRUG

CAR

Target A positive subjects will receive CAR-T cell therapy.

DRUG

TCR

Target A negative, Target B positive and Target C positive subjects will receive TCR-T cell therapy.

Trial Locations (1)

Unknown

RECRUITING

Fudan University, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER